MedPath

Does Stellate ganglion block provide any benefit in the treatment of patients with moderate to severe anxiety who have failed standard treatment.

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/02/063259
Lead Sponsor
Sri Madhusudan Sai Institute of Medical Sciences and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adults with treatment resistant anxiety disorder who score ?10 on GAD-7 questionnaire and are willing to consent.

Exclusion Criteria

1.Participants unwilling to provide consent

2.Participants with known history of drug allergy to bupivacaine, lidocaine or depot methylprednisolone

3.Recent myocardial infarction

4.Patients on anti-coagulants or dual anti-platelet drugs

5.Glaucoma

6.Severe COPD

7.Cardiac conduction block

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath